Two Liberian Doctors To Receive Experimental Ebola Drug, But Supplies Now 'Exhausted'

Two Liberian doctors infected with the Ebola virus will receive the potentially lifesaving ZMapp, an experimental treatment, but the drug's maker says its supply is now exhausted. Mapp Biopharmaceuticals said in a statement it provided the drug free of cost to every properly authorized entity that requested it but did not specify who made those requests.